Literature DB >> 16830485

Applications of silica supports in affinity chromatography.

John E Schiel1, Rangan Mallik, Sony Soman, Krina S Joseph, David S Hage.   

Abstract

The combined use of silica-based chromatographic supports with immobilized affinity ligands can be used in many preparative and analytical applications. One example is the use of silica-based affinity columns in HPLC, giving rise to a method known as high-performance affinity chromatography (HPAC). This review discusses the role that silica has played in the development of affinity chromatography and HPAC and the applications of silica in these methods. This includes a discussion of the types of ligands that have been employed with silica and the methods by which these ligands have been immobilized. Various formats have also been presented for the use of silica in affinity chromatographic methods, including assays involving direct or indirect analyte detection, on-line or off-line affinity extraction, and chiral separations. The use of silica-based affinity columns in studies of biological systems based on zonal elution and frontal analysis methods will also be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830485     DOI: 10.1002/jssc.200500501

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  23 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Immunoaffinity chromatography: an introduction to applications and recent developments.

Authors:  Annette C Moser; David S Hage
Journal:  Bioanalysis       Date:  2010-04       Impact factor: 2.681

Review 3.  Affinity chromatography: A review of trends and developments over the past 50 years.

Authors:  Elliott L Rodriguez; Saumen Poddar; Sazia Iftekhar; Kyungah Suh; Ashley G Woolfork; Susan Ovbude; Allegra Pekarek; Morgan Walters; Shae Lott; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-08-14       Impact factor: 3.205

Review 4.  Affinity monolith chromatography: A review of general principles and applications.

Authors:  Zhao Li; Elliott Rodriguez; Shiden Azaria; Allegra Pekarek; David S Hage
Journal:  Electrophoresis       Date:  2017-05-22       Impact factor: 3.535

5.  Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling.

Authors:  Sandya Beeram; Cong Bi; Xiwei Zheng; David S Hage
Journal:  J Chromatogr A       Date:  2017-03-23       Impact factor: 4.759

6.  Development of an affinity silica monolith containing human serum albumin for chiral separations.

Authors:  Rangan Mallik; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2007-03-24       Impact factor: 3.935

7.  Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.

Authors:  Mandi L Conrad; Annette C Moser; David S Hage
Journal:  J Sep Sci       Date:  2009-04       Impact factor: 3.645

Review 8.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

9.  Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.

Authors:  K S Joseph; Annette C Moser; Sara B G Basiaga; John E Schiel; David S Hage
Journal:  J Chromatogr A       Date:  2008-10-01       Impact factor: 4.759

Review 10.  Kinetic studies of biological interactions by affinity chromatography.

Authors:  John E Schiel; David S Hage
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.